Repeated doses of Praziquantel in Schistosomiasis Treatment (RePST) – single versus multiple praziquantel treatments in school-aged children in Côte d’Ivoire: a study protocol for an open-label, randomised controlled trial

Repeated doses of Praziquantel in Schistosomiasis Treatment (RePST) – single versus multiple praziquantel treatments in school-aged children in Côte d’Ivoire: a study protocol for an open-label, randomised controlled trial

Abstract Background Large scale administration of the anthelminthic drug praziquantel (PZQ) to at-risk populations is the cornerstone of schistosomiasis control, although persisting high prevalence of infections in some areas and growing concerns of PZQ resistance have revealed the limitations of th...

Full description

Bibliographic Details
Main Authors: P. T. Hoekstra, M. Casacuberta Partal, A. S. Amoah, L. van Lieshout, P. L. A. M. Corstjens, S. Tsonaka, R. K. Assaré, K. D. Silué, A. Meité, E. K. N’Goran, Y. K. N’Gbesso, M. Roestenberg, S. Knopp, J. Utzinger, J. T. Coulibaly, G. J. van Dam
Format: Article
Language:English
Published: BMC 2018-12-01
Series:BMC Infectious Diseases
Subjects:
Schistosomiasis
Schistosoma mansoni
Praziquantel
Treatment efficacy
Diagnostic test
Kato-Katz
Online Access:http://link.springer.com/article/10.1186/s12879-018-3554-2

Similar Items

Similar Items